Key trial programs include SURMOUNT (tirzepatide for weight management, NEJM 2022), SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024), and STEP (semaglutide, NEJM 2021)
it has been tied to delta-wave EEG activity, neurotransmitter changes, motor recovery in rat stroke models, and HPA-axis signaling
A rare cause of drug-induced hepatitis in an immunocompromised patient and the role of glutathione
Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes
We encourage all prospective patients to schedule a personalized consultation with Dr
Ongoing monitoring Regular follow-up appointments allow your provider to track progress, adjust dosing, manage any side effects, and provide accountability and support